The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825.
 
Renke Zhou
No Relationships to Disclose
 
Michael E. Scheurer
No Relationships to Disclose
 
Mark R. Gilbert
Honoraria - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck; Wellcome Trust
Consulting or Advisory Role - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck/Schering Plough; Wellcome Trust
Research Funding - Genentech/Roche; GlaxoSmithKline; Merck/Schering Plough
Travel, Accommodations, Expenses - Abbvie; Genentech/Roche; Merck/Schering Plough
 
Melissa Bondy
No Relationships to Disclose
 
Erik P. Sulman
Honoraria - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Ying Yuan
No Relationships to Disclose
 
Yanhong Liu
No Relationships to Disclose
 
Elizabeth Vera
Employment - Horizon Health
 
Merideth M Wendland
No Relationships to Disclose
 
David Brachman
Stock and Other Ownership Interests - GammaTile
Patents, Royalties, Other Intellectual Property - GEmmaTile, LLC
Other Relationship - GammaTile
 
James Bearden
No Relationships to Disclose
 
Susan Lynne McGovern
No Relationships to Disclose
 
Steven S. Wilson
No Relationships to Disclose
 
Kevin D. Judy
No Relationships to Disclose
 
H. Ian Robins
No Relationships to Disclose
 
Grant Kirton Hunter
No Relationships to Disclose
 
Stephanie L Pugh
No Relationships to Disclose
 
Terri S. Armstrong
Consulting or Advisory Role - ImmunoCellular Therapeutics; Tocagen
Research Funding - Merck/Schering Plough